Lung Cancer Committee

Purpose

The purpose of the NRG Oncology Lung Cancer Committee is to pursue novel therapeutic strategies toward improving progression-free and overall survival and quality of life for patients with non-metastatic disease.

The Committee’s Research priorities include optimizing therapy for patients with both early-stage and locally-advanced lung cancers. Early-stage NSCLC is a heterogeneous patient population, in terms of radiation dose, organs-at-risk, and systemic therapy management. The prognosis for patients with both locally advanced small cell and non-small cell lung cancer is rapidly improving, with the need for further individualized treatment strategies to optimize outcomes based on molecular and anatomical characteristics. 

This Committee meets via monthly conference calls and in-person at the NRG Meetings.

 

Lung Cancer Committee Leadership

Chair

Kristin Higgins, MD

Vice Chair

Jessica Donington, MD

Vice Chair

Martin Edelman, MD

Immediate Past Chair

Jeffrey Bradley, MD
Working Groups

Translational Science Lung Cancer Working Group

Chair

Bo Lu, MD, PhD

Core Committee Members

Core Members

  • Raid Aljumaily
  • Shahed Badiyan
  • Andrew Baschnagel
  • Tammy Bausinger
  • Tithi Biswas
  • Jeff Bradley
  • Stephen Chun
  • James Dignam
  • Jessica Donington
  • Martin Edelman
  • Aaron Franke
  • Carl Michael Gay
  • Daphna Gelblum
  • Michelle Ginsberg 
  • Daniel Gomez
  • Vinai Gondi
  • Inga Grills
  • Mark Harkenrider
  • John H. Heinzerling
  • Brian S Henick
  • John Heymach
  • Kristin Higgins
  • Chen Hu
  • Puneeth Iyengar
  • Salma Jabbour
  • Aparna H. Kesarwala
  • Spring Kong
  • Sameera Kumar
  • Vincent Lam
  • Corey Langer
  • Brianna Caroline Lau
  • Ticiana Leal
  • Xing Liao
  • Steven Lin
  • Bo Lu
  • Neal 
    S. McCall

  • Gregory Masters
  • Martha Matuszak
  • Drew Moghanaki
  • Ben Movsas
  • Abdul Rafeh Naqash
  • Quynh-Nhu Nguyen
  • Nitin Ohri
  • Pradnya D. Patil
  • Rebecca Paulus
  • Bradford A. Perez
  • Jen Petrask
  • Jennifer Presley
  • David Qian
  • Andreas Rimner
  • Clifford Robinson
  • Pam Samson
  • Rafael Santana-Davila
  • Tom Simon
  • Charles Simone
  • Heath Skinner
  • Nancy Soto
  • Alexander Sun
  • Sibo Tian
  • Robert Timmerman
  • Theos Tsakiridis
  • Anne Tsao
  • James Urbanic
  • Gregory Videtic
  • Lucus Vitzthum
  • Saiama Waqar
  • Ashley A. Weiner
  • James Welsh
  • Kathryn Winter

General Members

  • Laura Alder
  • Fiori Alite
  • Raid Aljumaily
  • Shahed Badiyan
  • Andrew Baschnagel
  • Tammy Bausinger
  • Eric H. Bernicker
  • Tithi Biswas
  • Edward M. Bleta
  • Jeff Bradley
  • Jason Chan
  • Nirmal Choradia
  • Stephen Chun
  • Devika Das
  • Jessica Donington
  • Tai Dou
  • Martin Edelman
  • Daffolyn Rachael Fels Elliott
  • Matthew J. Ferris
  • Aaron Franke
  • Carl Michael Gay
  • Daphna Gelblum
  • Oleg Gligich
  • Daniel Gomez
  • Vinai Gondi
  • Ramesh Gopal
  • Mark Harkenrider
  • John Heymach
  • Kristin Higgins
  • Chen Hu
  • Puneeth Iyengar
  • Salma Jabbour
  • Paul Koffer
  • Spring Kong
  • Sameera Kumar
  • Vincent Lam
  • Corey Langer
  • Brianna Caroline Lau
  • Ticiana Leal
  • Xing Liao
  • Steven Lin
  • Bo Lu
  • Gregory Masters
  • Martha Matuszak
  • Inga Grills MD
  • Joseph A. Miccio
  • Ben Movsas
  • Quynh-Nhu Nguyen
  • Nitin Ohri
  • Cameron J. Oswalt
  • Pradnya D. Patil
  • Rebecca Paulus
  • Jen Petrask
  • Phillip Pifer
  • Jennifer Presley
  • Krishna Reddy
  • Andreas Rimner
  • Clifford Robinson
  • Pam Samson
  • Rafael Santana-Davila
  • Austin J. Sim
  • Tom Simon
  • Charles Simone
  • Heath Skinner
  • Nancy Soto
  • Janakiraman Subramanian
  • Alexander Sun
  • Robert Timmerman
  • Theos Tsakiridis
  • Anne Tsao
  • James Urbanic
  • Gregory Videtic
  • Lucus Vitzthum
  • Saiama Waqar
  • James Welsh
  • Kathryn Winter
  • Nathan Y. Yu
  • YuanYuan  Zhang     

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.